MENS — Jyong Biotech Ltd.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1954488 · Taiwan
Last close
$1.80
Market Cap
$133.62M
52W High
$38.88
52W Low
$1.43
ADV30
41,106
Next earnings
2026-11-18

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Dec 2025 — — — — 20,778,000 1,175,000 45,684,000
Jun 2025 — — — — 37,671,000 132,000 60,143,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-37,751,000
Inventory
—
Receivables
$13,510,000
ST Investments
$16,875,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -2,607,000 -4,671,000 20,778,000 45,684,000 -24,906,000 -3,041,000
Dec 2024 0 -2,056,000 -3,019,000 6,366,000 42,885,000 -36,519,000 -3,624,000
Dec 2023 0 -2,797,000 -4,400,000 8,248,000 42,321,000 -34,073,000 -2,601,000
Dec 2022 0 -2,829,000 -6,630,000 8,745,000 38,376,000 -29,631,000 -2,971,000
Dec 2021 — — — — — — —

Peers — same industry

TickerNameMarket CapLastDaily %
MSLE Satellos Bioscience Inc. $131.54M $6.20 —
MGNX MACROGENICS INC $131.01M $2.05 —
SION Sionna Therapeutics, Inc. $138.87M $3.07 —
ALXO ALX ONCOLOGY HOLDINGS INC $138.97M $1.00 —
RNA Atrium Therapeutics, Inc. $139.78M $6.48 —

News headlines (Yahoo Finance, 1h cache)

Jyong Biotech to Host Two-Day Investor Events in Silicon Valley and Irvine, California
2026-10-21 12:00 · Yahoo
Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug Candidates
2026-10-16 00:00 · Yahoo
Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow
2026-09-03 12:00 · Yahoo
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
2026-07-23 14:52 · Yahoo
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
2026-07-03 00:00 · Yahoo
Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio
2026-04-29 00:00 · Yahoo
Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025
2026-05-15 12:30 · Yahoo
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
2026-06-01 00:00 · Yahoo
Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2
2026-03-28 00:00 · Yahoo
Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongsi
2026-02-13 00:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.